دورية أكاديمية
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
| العنوان: | Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial |
|---|---|
| المؤلفون: | Spring, L.M., Tolaney, S.M., Fell, G., Bossuyt, V., Abelman, R.O., Wu, B., Maheswaran, S., Trippa, L., Comander, A., Mulvey, T., McLaughlin, S., Ryan, P., Ryan, L., Abraham, E., Rosenstock, A., Garrido-Castro, A.C., Lynce, F., Moy, B., Isakoff, S.J., Tung, N., Mittendorf, E.A., Ellisen, L.W., Bardia, A. |
| المساهمون: | Gilead Sciences |
| المصدر: | Annals of Oncology ; volume 35, issue 3, page 293-301 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2024 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2023.11.018 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2023.11.018Test https://api.elsevier.com/content/article/PII:S0923753423051074?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753423051074?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.D2C02176 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2023.11.018 |
|---|